NEW YORK, July 11 – In the often-contentious world of private versus public genomic initiatives, everybody appears to be happy about the National Cancer Institute’s subscription agreement with Celera Genomics.

The deal, which allows individual NCI principal investigators to use lab budgets to access the data and tools in the Celera Discovery System and mouse and SNP datasets, was six months in the making, according to sources at NCI and Celera. The agreement was announced on Monday. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.